Average Co-Inventor Count = 4.39
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (15 from 3,684 patents)
2. Rutgers, the State University of New Jersey (1 from 1,455 patents)
3. Lexicon Pharmaceuticals, Inc. (86 patents)
16 patents:
1. 10525021 - Mitochondrial uncouplers for treatment of metabolic diseases and cancer
2. 6897321 - Process for preparing azacycloalkanoylaminothiazoles (LD 137e)
3. 6720347 - Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
4. 6639074 - Process for preparing azacycloalkanoylaminothiazoles
5. 6613911 - Process for preparing arylacetylaminothiazoles
6. 6610724 - 3-Aminopyrazole inhibitors of cyclin dependent kinases
7. 6534531 - Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy
8. 6521759 - Aminothiazole inhibitors of cyclin dependent kinases
9. 6482842 - 3-aminopyrazole inhibitors of cyclin dependent kinases
10. 6414156 - Process for preparing azacycloalkanoylaminothiazoles
11. 6407124 - Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
12. 6392053 - Process for preparing arylacetylaminothiazoles
13. 6262096 - Aminothiazole inhibitors of cyclin dependent kinases
14. 6214852 - N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
15. 6107305 - Use of pyrazolo [3,4-b] pyridine as cyclin dependent kinase inhibitors